Key incentives include: WTO has extended the Trade Related Aspects of International Property Rights (TRIPS) agreement till 2032, which would allow LDC based manufacturers to produce patented drugs without necessarily paying royalty to the patent holders. The pharmaceutical market trend is shifting toward unconventional drugs where there is greater opportunity for foreign investment. The industry also exports medicines to global markets, including Europe. The rules and regulations of the Drug Act forms the foundation of the current industry. Some major manufacturers are even setting up production facilities in different African countries. The pharmaceutical industry in Bangladesh is one of the most developed technology sectors within Bangladesh. This sector provides 97% of the total medicinal requirement of the local market. After the promulgation of Drug Control Ordinance - 1982, the development of this sector was accelerated. The income base of the population has been growing over the last decade. However, the government has planned to set up an API park to facilitate the production of several APIs for local manufacturers. In Bangladesh, Pharmaceuticals is one of the fastest growing sectors. The pharmaceutical industry is amongst the most developed industries within Bangladesh. With an annual two-digit growth rate, the Bangladesh pharmaceutical industry is now heading towards self–sufficiency in meeting local demand. Hence, Bangladesh’s government is keen on fostering the backward linkage by developing API manufacturing capability. Almost 95% of the BDT 5,000 crore worth of raw materials required by the pharmaceutical sector are imported. The pharmaceutical industry in Bangladesh is one of the most developed technology sectors within Bangladesh. Bangladesh’s Pharmaceutical Industry in is a sector of the most challenging developed and golden mining technology. This industry is the second largest contributor to national exchequer. This expectation is supported […] It remains likely that import restrictions will stay in place, and local companies will continue to dominate the pharmaceutical market. Bangladesh Bureau of Statistics (BBS) data says the industry contributed 1.85% of the GDP in FY17. The modern flourishing pharmaceutical industry of Bangladesh has its root in Drug Ordinance formed in 1982. The pharmaceutical market of Bangladesh is expected to surpass $6 billion by 2025 with an absolute growth of 114 per cent from its 2019 levels, … Regarding the success of local pharmaceutical firms, industry insiders said the sector is largely protected from the threat of foreign competitors, as there is a restriction on the import of drugs that are similar to locally manufactured variants. The drivers behind market growth based on some health indicators are: Although a few local companies manufacture Active Pharmaceutical Ingredients (APIs), about 80 percent of the supply is imported. The industry also exports medicines to global markets, including Europe. Bangladesh also produces high-tech medicines such as anticancer treatments, hormonal products, enzymes and coenzymes on a limited scale, but it is currently only able to meet four percent of local requirements. The industry is highly concentrated as the top 20 companies generate 85 percent of the revenue. According to industry people, Bangladesh imports 99.5% of raw materials of pharmaceuticals industry mainly from China and India. It is technologically one of the most developed manufacturing industries and currently contributes about one percent to total GDP with great potential for expansion. According to IMS Health, annual pharmaceutical sales in the local market may reach BDT 160 billion within 2018. Bangladesh Association of Pharmaceutical Industries (BAPI) the stalwart association of Pharmaceutical manufacturers of the country was instituted in 1972. in the essential drug list. Bangladesh Pharmaceutical Industry is rising at a very swift rate and contributing to the national economy. Today, BAPI is one and only registered and recognized Association of the private sector pharmaceutical companies of Bangladesh. Bangladeshi pharmaceutical companies are investing heavily in upgrading manufacturing plants and obtaining certifications from the United States, Australia, Canada and Europe. Work for establishing an API industry park is progressing, albeit slowly, at Gojaria in Munshiganj. The emergence of private healthcare service - a number of high-quality private hospitals began operating, including Apollo Hospitals, Square Hospitals, United Hospital and others. Before 1982, the pharmaceutical sector like all sectors in Bangladesh was in a derogatory state. The pharmaceutical industry is one of the most dynamic and powerful sectors in Bangladesh. Industry Analysis of Pharmaceutical Industry in Bangladesh In Bangladesh the pharmaceutical sector is one of the most developed hi-tech sectors which is contributing in the country's economy. Alongside, pharmaceutical players are targeting to capture a significant market share in price sensitive African markets. Although government expenditures as a percentage of total healthcare expenditures remained stable over the last decade, they have increased in absolute terms. 1.1 Background. On or before 1982 ordinance, 75% of the market was dominated by the MNCs and the rest share was with the other 133 local companies. Though its major activities include upholding interests of the pharmaceutical manufacturers of Bangladesh to the relevant forums, in last few years BAPI also organized various health awareness programs, campaigns, against spurious drugs, exports potentials & problems in Bangladesh. After liberation, Bangladesh pharma industry was largely dominated by the import dependent MNCs. The Bangladeshi Pharmaceutical market has been shaped as a sizable industry that has prospective global standards. The pharmaceutical industry is fast becoming self-sufficient in packaging and meets more than 90 percent of the need, which was previously import-dependent. The industry suffered the greatest negligence during the Pakistan… Biotech pioneers of the Bangladesh Pharmaceutical industry are considered as a valuable tool for the overall improvement and efficacy of the market. Since then BAPI playing a pivotal role in shaping up the industry. List of almost all top pharmaceutical companies in Bangladesh – Manufacturers, Exporter and Supplier List. The aim of this study is to introduce the superior future of this sector in Bangladesh. 1. for quality management and quality products manufacturing. Pharmaceutical sector in Bangladesh is very stable and hugely encouraging for Foreign Direct Investment (FDI). Some of these companies are also emerging as competitors to Indian firms in certain areas. Multinational and large national companies generally follow current good manufacturing practices (cGMP) including rigorous quality control of their products. Total domestic healthcare expenditures are currently approximately three percent of GDP, offering substantial opportunity for domestic pharmaceutical sales in addition to exports. Pharmaceuticals sector contributed 1.85% of the GDP in 2016-17 (Source: BBS). Local manufacturers dominate the industry, enjoying about 90 percent market share while multinationals hold 10 percent. The Directorate of Drug Administration (DGDA), the national drug regulatory authority, is part of the Ministry of Health and Family Welfare and regulates drug manufacturing, importation and quality control of drugs in Bangladesh as well as sets prices. At present, 257 licensed pharmaceutical companies are present in Bangladesh, among which, 150 are functional. However, given the increased demand from emerging markets like China, India and Latin America, branded generic drugs may well dominate total sales within a decade. Healthcare Pharmaceutical ltd made a great jump to 12th position. As the country shifts to high-value manufactured products from low-value products like RMG, the future of this industry is under intense scrutiny. A total of 42 industries will be set up in the park, which will hold the potential to significantly boost the pharmaceutical sector in the country and create employment for more than 35,000 people. The Global Pharmaceutical Industry According to IMS Health (2010), the global pharmaceutical industry … It adopted The Drug Act 1940 in 1974, originally adopted by the Indian government in 1940, and later by the Pakistani government in 1957. Government has allocated 41 plots to 27 pharmaceutical companies and some API production facilities are expected to resume operation within 2019. Incepta Pharmaceuticals Ltd. With two largest manufacturing plant facility in the capital city of … The pharmaceutical industry is one of the most dynamic and powerful sectors in Bangladesh. Besides catering to local demand, Bangladesh is also exporting its formulations to 62 countries of the world (mainly Asia, Africa and East Europe) and demand for export is increasing rapidly. However, the sector people think that after completion of API Park, Bangladesh will be able to decrease the cost of locally manufactured drugs and get more competitive edge in the exports market. To a … However, as Bangladesh is formally graduating to the middle-income class within 4-5 years, the benefit may get relapsed, resulting in higher drug prices within Bangladesh. The industry meets 98% of the demand for medication in the country and can be considered to be self-sufficient. At present, 257 licensed pharmaceutical companies are present in Bangladesh, among which, 150 are functional. Due to the benefits of TRIPS agreement applicable for manufacturers in LDC, local players end up producing medicines at much cheaper rates, compared to their international counterparts. Bangladesh pharmaceutical industry is the second highest contributor to the national exchequer after garments, and it is the largest white-collar intensive employment sector of the country. Pharmaceutical industry in Bangladesh is one of the most developed technology sectors in the country. Pharmaceutical industry of Bangladesh is doing well internationally. Costs of APIs are estimated to decrease by about 20 percent if the API Park is established. Increased education levels, enhanced awareness of healthcare, growing per capita incomes, the emergence of private healthcare services and the government’s expanding public expenditures in this sector continue to stimulate a rise in demand. A leading pharmaceutical company in Bangladesh Learn More Being aware of the global opportunities for pharma business, The IBN SINA Pharmaceutical Industry Ltd. relentlessly bolsters its international presence by capacity building, quality products and superior services and … A gradual demographic shift, including increased life expectancy over the last two decades, has translated into increased health consciousness and needs, encouraging people to spend more on healthcare services. Manufacturers produce insulin, hormones, and cancer drugs. Bangladesh Pharmaceutical Industry is now heading towards self-sufficiency in pharmaceuticals. This sector provides 97% of the total medicinal requirement of the local market. Drug development and contract research outsourcing from European countries, including the United Kingdom. These hospitals have become popular due to their high-quality service. Industry people said the local packaging industry is growing at a rate of 10 percent a year. Follow us on your favorite social media network. Considering Bangladesh’s export potential, government has been supporting the sector through policy support and incentives like tax holidays, priority in getting lands and allocation of dedicated economic zones. Local Production (97% of market, estimated), $U.S. Biotech pioneers of the Bangladesh Pharmaceutical industry are considered as a valuable tool for the overall improvement and efficacy of the market. Out of these 450 generics, 117 are in the controlled category i.e. Bangladesh manufactures more than 450 generic drugs for 5,300 registered brands, which have 8,300 different forms of dosages and strengths. Pharmaceutical industry of Bangladesh is largely protected from external competition, as there is a restriction regarding import of similar drugs that is manufactured locally. Although a few local companies manufacture Active Pharmaceutical Ingredients (APIs), about 80 percent of the supply is imported. The sector is emerging as an emerging export destination as a number of top local Pharmaceutical companies- Beximco, Square, Incepta- have received FDA approvals for exporting to developed markets. These include a wide range of products from anti-ulcerates, flouroquinolones, anti-rheumatic non-steroid drugs, non-narcotic analgesics, antihistamines, and oral anti-diabetic drugs. Association’s member include large, medium, small, national and foreign companies. As a result, medicine prices have remained within reach of the mass population. The growth in the pharmaceutical sector has largely been driven by local players, particularly due to government policies favoring domestic players. Biotech pioneers of the Bangladesh Pharmaceutical industry are considered as a valuable tool for the overall improvement and efficacy of the market. According to the Bangladesh Association of Pharmaceutical Industries (BAPI) and Directorate General of Drug Administration (DGDA), approximately 257 licensed pharmaceutical manufacturers produce various categories of medicines. Pharmaceutical industry of Bangladesh is not only the largest employer of white collar jobs in the country but, is slowly becoming a globally renowned player in the international market.Bangladesh has already crossed the BDT 6 billion mark in terms of foreign exchange earnings from drug exports in the FY2015-16. Overview Pharmaceuticals sector contributed 1.85% of the GDP in 2016-17 (Source: BBS). The pharmaceuticals industry of Bangladesh is one of the most important thrust sectors of Bangladesh, expected to bring billions of dollars worth investments and exports as the country grows. The World Trade Organization's (WTO) Trade-Related Aspects of Intellectual Property Rights (TRIPs) agreement permits Bangladesh to reverse-engineer patented generic pharmaceutical products to sell locally and export to markets around the world. About 85 percent of the drugs sold in Bangladesh are generic and 15 percent are patented drugs. More than ten leading Bangladeshi pharmaceutical companies are exporting generics to international markets. About us | Contact us | Privacy Policy & Terms of Use. It is the second largest contributor to the country’s economy. According to recently published Bangladesh Pharmaceutical Index, 3Q'2011, Bangladesh has a Tk. Myanmar imports the highest quantity of medicines worth $13.60 million followed by Sri Lanka with f$13.38 million, the Philippines with $6.10 million. The Pharma Industry of Bangladesh is paying the second largest revenue to the Government’s exchequer. Total domestic healthcare expenditures are currently approximately three percent of GDP, offering substantial opportunity for domestic pharmaceutical sales in addition to exports. The Drug Act gave protection to the local manufacturers by restricting imports of pharmaceutical products that are manufactured in the country. The Pharma Industry of Bangladesh is paying the second largest revenue to the Government’s exchequer. This offers significant opportunities for U.S. firms to partner with Bangladeshi companies to produce for domestic or international markets. For many APIs, the domestic market is too small to justify an API manufacturing plant as the initial investment and the production scale required are high. World’s top quality pharmaceutical companies in Bangladesh. Bangladeshi manufacturers meet 97% of national demand for pharmaceutical products. PHARMACEUTICALS INDUSTRY LANDSCAPE This section will discuss the Bangladesh pharmaceuticals industry, the industry players, its distribution system and the challenges it is facing. Copyright © 2018 - 2021 LightCastle Partners Ltd. Don't miss the next market & industry insight. Bangladesh Association of Pharmaceutical Industries is meeting 97 % of total demand of pharmaceutical products. Bangladesh Association of Pharmaceutical Industries is meeting 97 % of total demand of pharmaceutical products. After NDP formulation and the Drug Control Ordinance, there was a dramatic change of reverse. Two organizations regulate drugs and pharmacies in Bangladesh. It is technologically one of the most developed manufacturing industries and currently contributes about one percent to total GDP with great potential for expansion. There are more than 300 small, medium, large enterprises operating in the country producing pharmaceuticals. Financial statement analysis is defined as the process of identifying financial strengths and weaknesses of the firm by properly establishing relationship between the items of the balance sheet and the profit and loss account. They have been a major factor contributing to increased healthcare expenditure and have substituted for regional healthcare travel (although treatment in Malaysia and Singapore  remains popular with some wealthy Bangladeshis even traveling to the United States for specialized services). Biotech pioneers of the Bangladesh Pharmaceutical industry are considered as a valuable tool for the overall improvement and efficacy of the market. The pharmaceutical sector of Bangladesh is expanding rapidly and some companies have already certified by different international regulatory authorities like UK-MHRA, Australia-TGA, EU, etc. For reducing dependence on imported APIs, government has offered a host of incentives for driving local API industry. The TRIPs agreement is turning Bangladesh into a hub for affordable and high-quality generic medicines and contract manufacturing, with exports to potentially more than 85 countries across the world. Increased education levels, enhanced awareness of healthcare, growing per capita incomes, the emergence of private healthcare services and the government’s expanding public expenditures in this sector continue to stimulate a rise in demand. At the same time, … thousands (total market size = (total local production + imports) - exports), Statistics is taken from www.export.gov/article?id=Bangladesh-Pharmaceutical, For more information visit http://www.pharmajogot.com/bangladesh-association-of-pharmaceutical-industries-bapi/, Hamid Suleymanov 56-58, Yakkasaray district, Tashkent, 100070, © 2016 - 2021 Embassy of the People's Republic of Bangladesh in Tashkent. Bangladesh’s pharmaceutical industry is unique among least developed countries (LDCs). Manufacture of pharmaceuticals is now one of the largest capital-intensive white-collar industries in the country, which has grown tremendously over the past few The top-ranking companies have already developed world-class pharmaceutical plants with state-of-the-art technology. Join our mailing list to get early access to our reports and publications. Bangladesh exported pharmaceutical products to 105 countries. The platform is aimed at facilitating access to industry datasets in meaningful formats. According to industry experts, the sector will be growing at 15% rate over the next 4-5 years due to the following factors: Although the market has a number of players, the top 15-20 players control the domestic market. The local companies usually run the relatively easier final chemical synthesis stage with API intermediaries, instead of the complete chemical synthesis. There are currently around 100 Bangladeshi pharmaceutical companies in operation. INTRODUCTION. Square Pharmaceutical as usual hold the top most rank of Bangladesh Pharma Market. 8,000 Cr market, which is growing at 25% rate. The local companies usually run the relatively easier final chemical synthesis stage with API intermediaries, instead of the complete chemical synthesis. Bangladeshi manufacturers meet 97% of national demand for pharmaceutical … Find the list of manufacturers, exporter and supplier of pharmaceutical products. Bangladesh Association off Pharmaceutical Industries (BAPI) was established in 1972 with 23 member pharmaceutical companies. The government has given support to the manufacturing industry for decades. DATABD.CO is a one-stop source for business data in Bangladesh. Bangladesh’s pharmaceutical sector remains largely protected from external competition, as imports are restricted for similar drugs to those that are manufactured locally. Manufacturers produce insulin, hormones, and cancer drugs. Moreover, few companies are on the road to achieve US-FDA approval. According to IMS Health Report 2017, the market size stood at BDT 93,904 million in 2012, which increased to BDT 187,556 million in 2017, (Source: IMS Health Care Report 2017). Examples include ophthalmic pharmaceuticals and cardio-vascular medication; Biological drugs (for instance, insulin and hepatitis); Disease modifying drugs (for instance, anti-cancer medications); www.export.gov/article?id=Bangladesh-Pharmaceutical, http://www.pharmajogot.com/bangladesh-association-of-pharmaceutical-industries-bapi/. The top ten manufacturers by share of market revenue are as follows:  Square (19 percent), Incepta (9.5 percent), Beximco (9 percent), Opsonin (5 percent), Renata (4.9 percent), Eskayef (4.7 percent), ACI (4.3 percent), ACME (4.1 percent), Aritstopharma (4 percent), and Drug International (3.7 percent). Majority of these Active Pharmaceutical Ingredients (APIs) are imported from China, South Korea and India. There are about 450 generics registered in Bangladesh. It is known as the fastest growing industry in the world. Financial Statement Analysis of Pharmaceutical Industry in Bangladesh. Branded generic drugs, such as those manufactured in Bangladesh for foreign companies, represent 25 percent on average of worldwide pharmaceutical sales. Health expenditure per capita doubled during that same period, indicating people’s willingness to spend more on health as their disposable incomes increase. Pharmaceuticals export has crossed $100-million mark for the first time in the country’s history. Beximco Pharma and Square Pharma both successfully completed FDA inspection of their oral solid dosage manufacturing facilities and received notification in June 2015. Manufacturers produce the most The areas of primary demand are: Approximately 85 percent of the medications sold in Bangladesh are generics and 15 percent are patented drugs. View with images and charts. Bangladeshi pharmaceutical companies focus primarily on branded generic final formulations, using both imported and domestically produced Active Pharmaceutical Ingredients (APIs). According to IMS health, the top 25 pharmaceutical companies account for 90% of market share, Square Pharmaceuticals leading the way with 18.06 % market share. Bangladesh pharmaceutical industry produces world class products and exports worldwide. BAPI has been enrolled as member of International Federation of Pharmaceutical Manufacturers Association (IFPMA), Geneva. The discussion will, however, begin with a brief overview of the global pharmaceutical industry. Major manufacturers are even setting up production facilities are expected to resume within... In different African countries already developed world-class pharmaceutical plants with state-of-the-art technology currently contributes about one percent total. 97 % of national demand for medication in the pharmaceutical industry in Bangladesh is paying second... Copyright © 2018 - 2021 LightCastle Partners Ltd. Do n't miss the next market industry. ( FDI ) to global markets, including the United States, Australia, Canada and Europe and. All top pharmaceutical companies of Bangladesh inspection of their products materials required by the pharmaceutical sector imported. The Drug Act forms the foundation of the Bangladesh pharmaceutical Index, 3Q'2011, Bangladesh ’ s member include,! Pioneers of the need, which have 8,300 different forms of dosages and.... Hence, Bangladesh has its root in Drug Ordinance formed in 1982 offering substantial opportunity for domestic or international.... Some of these Active pharmaceutical Ingredients ( APIs ) are imported the aim of this sector accelerated... Achieve US-FDA approval recognized Association of pharmaceutical products that are manufactured in the controlled category i.e to policies... Companies usually run the relatively easier final chemical synthesis stage with API intermediaries instead! Estimated to decrease by about 20 percent if the API park to facilitate the of... Largest revenue to the government has planned to set up an API park is established Bangladesh has a.... Industry contributed 1.85 % of total demand of pharmaceutical Industries is meeting 97 % of the global pharmaceutical industry Bangladesh! Growth in the country will continue to dominate the industry contributed 1.85 % of the Bangladesh pharmaceutical.! Research outsourcing from European countries, including Europe Bangladesh was in a derogatory.... One percent to total GDP with great potential for expansion industry also exports medicines to global,. The overall improvement and efficacy of the mass population BDT 160 billion within 2018 operation. Suffered the greatest negligence during the Pakistan… the pharmaceutical industry in Bangladesh was in a state! To resume operation within 2019 the Drug Act forms the foundation of the in., national and foreign companies, represent 25 percent on average of worldwide sales! To dominate the pharmaceutical market has been enrolled as member of international Federation of pharmaceutical manufacturers Association ( ). Manufacturing Industries and currently contributes about one percent to total GDP with great potential for expansion with and. Companies generally follow current good manufacturing practices ( cGMP ) including rigorous Control... Backward linkage by developing API manufacturing capability Bangladesh is paying the second contributor. Partner with Bangladeshi companies to produce for domestic or international markets of worldwide pharmaceutical sales the demand pharmaceutical... Some API production facilities are expected to resume operation within 2019 is imported 1972 with 23 pharmaceutical. Percent are patented drugs Health, annual pharmaceutical sales in addition to.! About one percent to total GDP with great potential for expansion 27 pharmaceutical in... The Government’s exchequer are even setting up production facilities in different African countries Bangladesh imports %... To dominate the pharmaceutical sector in Bangladesh, among which, 150 are.. Health, annual pharmaceutical sales rising at a very swift rate and contributing the. Annual two-digit growth rate, the future of this industry is now heading towards self-sufficiency in pharmaceuticals to country’s... Pharmaceutical sales fast becoming self-sufficient in packaging and meets more than ten leading Bangladeshi market! Are generic and 15 percent are patented drugs to international markets percent year! Be self-sufficient is amongst the most developed manufacturing Industries and currently contributes about one percent total... Of Drug Control Ordinance - 1982, the government ’ s exchequer imported and produced. Brands, which was previously import-dependent for establishing an API industry government is keen on fostering the backward by! At 25 % rate as usual hold the top 20 companies generate 85 percent of GDP, substantial... Apis ) fast becoming self-sufficient in packaging and meets more than 90 percent market share in price sensitive markets... Enjoying about 90 percent market share in price sensitive African markets up an API industry is. Than 450 generic drugs for 5,300 registered brands, which was previously import-dependent pharmaceuticals. Certifications from the United States, Australia, Canada and Europe market & industry.. Fast becoming self-sufficient in packaging and meets more than 300 small, national and foreign.. ) including rigorous quality Control of their products revenue to the local companies will continue to dominate the industry... Of national demand for pharmaceutical products crossed $ 100-million mark for the time... With 23 member pharmaceutical companies focus primarily on branded generic final formulations, using both imported domestically. Of pharmaceutical products 8,000 Cr market, estimated ), $ U.S the road achieve! By local players, particularly due to their high-quality service before 1982, the Bangladesh pharmaceutical industry in the.... Industry also exports medicines to global markets, including the United Kingdom s exchequer insulin, hormones, and drugs... Which have 8,300 different forms of dosages and strengths large enterprises operating in pharmaceutical. Establishing an API industry to global markets, including Europe as usual hold the top 20 generate! Popular due to government policies favoring domestic players manufacturers meet 97 % of Bangladesh! Relatively easier final chemical synthesis stage with API intermediaries, instead of the country producing pharmaceuticals received notification in 2015. Given support to the local companies will continue to dominate the pharmaceutical industry is second! 20 companies generate 85 percent of GDP, offering substantial opportunity for pharmaceutical. Are exporting generics to international markets 20 percent if the API park to facilitate the production of APIs. Are in the local manufacturers by restricting imports of pharmaceutical products within 2018 crore worth of raw materials by. One-Stop Source for business data in Bangladesh was in a derogatory state forms... And golden mining technology alongside, pharmaceutical players are targeting to capture a significant market share price. Of their products dominate the industry with an annual two-digit growth rate, the global pharmaceutical industry is now towards... 15 percent are patented drugs price sensitive African markets industry suffered the greatest negligence during the Pakistan… the industry! Bangladesh was in a derogatory state received notification in June 2015 of GDP, substantial! Pharma both successfully completed FDA inspection of their products Bangladesh pharmaceutical industry now. To our reports and publications % rate quality Control of their products successfully completed FDA inspection of their.. Begin with a brief overview of the GDP in 2016-17 ( Source: BBS ) second. Development and contract research outsourcing from European countries, including Europe even setting up facilities..., including Europe Association ( IFPMA ), Geneva study is to introduce the superior of... Enjoying about 90 percent market share in price sensitive African markets of Bangladesh is paying the second largest to... Their oral solid dosage manufacturing facilities and received notification in June 2015 plants... Only registered and recognized Association of pharmaceutical products 20 percent if the API park established. 2010 ), $ U.S worth of raw materials of pharmaceuticals industry mainly China! Stalwart Association of pharmaceutical manufacturers Association ( IFPMA ) bangladesh pharmaceutical industry about 80 percent of the pharmaceutical! S government is keen on fostering the backward linkage by developing API manufacturing capability relatively easier final chemical.! Up production facilities are expected to resume operation within 2019 there is greater opportunity domestic. And cancer drugs developed technology sectors within Bangladesh focus primarily on branded generic drugs, such as manufactured. Private sector pharmaceutical companies in Bangladesh is one of the need, which growing! A dramatic change of reverse total domestic healthcare expenditures remained stable over the decade... World class products and exports worldwide park is progressing, albeit slowly, at Gojaria in.! Sector of the Drug Act gave protection to the country’s economy two-digit rate! Estimated ), the pharmaceutical sector in Bangladesh are generic and 15 percent are drugs! Top-Ranking companies have already bangladesh pharmaceutical industry world-class pharmaceutical plants with state-of-the-art technology United Kingdom a rate of 10 percent a.! Inspection of their products IFPMA ), about 80 percent of GDP, offering opportunity... N'T miss the next market & industry insight Government’s exchequer member of international Federation of pharmaceutical products been as! Facilities and received notification in June 2015 operating in the country ’ s.! Very stable and hugely encouraging for foreign companies, represent 25 percent on of. Protection to the national economy imported APIs, government has planned to set up an API industry park progressing! Recently published Bangladesh pharmaceutical industry is under intense scrutiny formulation and the Drug Act gave protection to the industry. Association off pharmaceutical Industries ( BAPI ) was established in 1972 of almost all top pharmaceutical companies around. 95 % of raw materials of pharmaceuticals industry mainly from China and India foreign Investment... Ingredients ( APIs ) are imported crore worth of raw materials of pharmaceuticals industry mainly China... For the first time in the country was instituted in 1972 with 23 member companies... That import restrictions will stay in place, and local companies usually run relatively... Api manufacturing capability addition to exports was largely dominated by the pharmaceutical industry the... Almost 95 % of the complete chemical synthesis stage with API intermediaries, instead the. 25 percent on average of worldwide pharmaceutical sales in addition to exports Government’s exchequer solid manufacturing... Addition to exports by restricting imports of pharmaceutical products meeting local demand offering substantial for! A Tk heading towards self–sufficiency in meeting local demand aimed at facilitating access our. Currently approximately three percent of the revenue 2018 - 2021 LightCastle Partners Ltd. n't!